DUBLIN, November 30, 2021--(BUSINESS WIRE)--The "Whole Genome and Exome Sequencing Markets by Application, Organism and Product with Executive and Consultant Guides. Includes Direct to Consumer Analysis - 2022 to 2026 " report has been added to ResearchAndMarkets.com's offering.
The COVID Pandemic has created a surge in Whole Genome Sequencing of Pathogens but cancer related activity has suffered. Find out all about it in the comprehensive report of Whole Genome Sequencing. The complete genome of the COVID virus is included as an example of the work being done.
Will all newborns receive Whole Genome Sequencing at birth? How fast will Direct to Consumer Testing grow? What sequencing technology will take the lead? What's holding the industry back? Where are the over 800 locations that have high throughput devices?
Our facts and support = Your success.
A plummeting of costs for Whole Genome Sequencing is creating a gold rush for market players. New consumers, new technologies, new specializations. In a situation reminiscent of the birth of the internet industry a wide range of well funded players is racing for market share on a truly global stage. The report forecasts the market size out to 2023. The report includes detailed breakouts for 14 countries and 5 regions.
Tumor Cell Sequencing? Direct to Consumer? Gene Expression? Find out about the technology in readily understood terms that explain the jargon. What are the issues? Find the opportunities and the pitfalls. Understand growth expectations and the ultimate market forecasts for the next five years.
This research will make you the expert in your organization. Get the research team working for you by ordering all, or a portion, of this comprehensive report. All report data is available in Excel format on request. Make investment decisions and valuations with confidence using the latest data.
Factors Driving Growth
Interpreting the Code Otherwise
Changes in Agriculture
Fertility Technology Comes of Age
Factors Limiting Growth
Increased Competition Lowers Price
Healthcare Cost Concerns Curtail Growth
Wellness has a downside
GMO Opposition Movement
10x Genomics, Inc.
Admera Health, LLC
Agena Bioscience, Inc.
Baylor Miraca Genetics Laboratories
Beckman Coulter Diagnostics
Becton, Dickinson and Company
BGI Genomics Co. Ltd
Bio-Rad Laboratories, Inc
Caris Molecular Diagnostics
Complete Genomics, Inc. - A BGI Company
Datar Cancer Genetics Limited
Day Zero Diagnostics
FUJIFILM Wako Diagnostics
GE Global Research
GE Healthcare Life Sciences
Genetron Health (Beijing) Co., Ltd.
Genomics Personalized Health (GPH)
HTG Molecular Diagnostics
Human Longevity, Inc.
MDNA Life SCIENCES, Inc.
Novogene Bioinformatics Technology Co., Ltd.
Oxford Nanopore Technologies
Personal Genome Diagnostics
Roche Molecular Diagnostics
Singlera Genomics Inc.
Sure Genomics, Inc.
Tempus Labs, Inc.
Thermo Fisher Scientific Inc.
For more information about this report visit https://www.researchandmarkets.com/r/1pp4ec
View source version on businesswire.com: https://www.businesswire.com/news/home/20211130005837/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900